Current research status in pharmaceutical care;Estado actual de la investigación en atención farmacéutica

Farmacia Hospitalaria

Volumn 29, Issue 5, 2005, Pages 335-342

  Rangel Mayoral, Juan Francisco ^a   Luis Fernandez J ^a   Liso Rubio, F J ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

Author keywords

Health outcomes research; Health related quality of life; Pharmaceutical care; Result assessment

Indexed keywords

ASTHMA; BIBLIOGRAPHIC DATABASE; CLINICAL PHARMACY; COCHRANE LIBRARY; DIABETES MELLITUS; ECONOMIC ASPECT; FOLLOW UP; HYPERLIPIDEMIA; HYPERTENSION; INFECTION; IOWA DRUG INFORMATION SYSTEM; MEDLINE; METHODOLOGY; OBSERVATIONAL METHOD; OUTCOME ASSESSMENT; OUTCOMES RESEARCH; PATIENT COMPLIANCE; PATIENT SATISFACTION; PHARMACEUTICAL CARE; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZATION; REVIEW; SCISEARCH; SHORT FORM 36; TESEO;

EID: 30544437830     PISSN: 11306343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1130-6343(05)73689-8     Document Type: Review

References (75)

1. Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Developing guidelines. BMJ 1999; 318: 593-6.
2. Moher D, Schulz KF, Altman DG. CONSORT GROUP (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134: 657-62. Disponible en: http://www.consort-statement.org (Acceso, noviembre de 2004).
3. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12.
4. Carter BL, Malone DC, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. Impact of Managed Pharmaceutical care on resource utilization and Outcomes in Veterans affairs medical centers. Interpreting the findings of the IMPROVE study. Am J Health Syst Pharm 2001; 58: 1330-7.
5. Álvarez F, Arcos P, Eyaralar T, Abal F, Dago A, Cabiedes L, et al. Pharmaceutical care in people who have had acute coronary episodes (TOMCOR study). Rev Esp Salud Pública 2001; 75: 375-87.
6. Cordina M, McElnay JC, Hughes CM. Assessment of a community pharmacy-based program for patients with asthma. Pharmacotherapy 2001; 21: 1196-203.
7. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care 2001; 39: 113-22.
8. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci 2003; 25: 218-26.
9. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Effectiveness of pharmacist care for patients with reactive airways disease: a randomized controlled trial. JAMA 2002; 288: 1594-602.
10. Brook OH, Van Hout HP, Nieuwenhuysea H, De Haan M. Effects of coaching by community pharmacists on psychological symptoms of antidepressant users; a randomised controlled trial. Eur Neuropsychopharmacol 2003; 13: 347-54.
11. Garcao JA, Cabrita J. Evaluation of a pharmaceutical care program for hypertensive patients in rural Portugal. J Am Pharm Assoc (Wash) 2002; 42: 858-64.
12. Stergachis A, Gardner JS, Anderson MT, Sullivan SD. Improving pediatric asthma outcomes in the community setting: does pharmaceutical care make a difference? J Am Pharm Assoc (Wash) 2002; 42: 743-52.
13. Varma S, McElnay JC, Hughes CM, Passmore AP, Varma M. Pharmaceutical care of patients with congestive heart failure: interventions and outcomes. Pharmacotherapy 1999; 19: 860-9.
14. Bernsten C, Bjorkman I, Caramona M, Crealey G, Frokjaer B, Grundberger E, et al. Pharmaceutical care of the Elderly in Europe Research (PEER) Group. Improving the well-being of elderly patients via-community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging 2001; 18: 63-77.
15. Volume CI, Farris KB, Kassam R, Cox CE, Cave A. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc (Wash) 2001; 41: 411-20.
16. Al-Rashed SA, Wright DJ, Roebuck N, Sunter W, Chrystyn H. The value of inpatient pharmaceutical counselling to elderly patients prior to discharge. Br J Clin Pharmacol 2002; 54: 657-64.
17. Dayton CS, Ferguson JS, Hornick DB, Peterson MW. Evaluation of an Internet-based decision-support system for applying the ATS/CDC guidelines for tuberculosis preventive therapy. Med Decis Making 2000; 20: 1-6.
18. Vivian EM. Improving blood pressure control in a pharmacist-managed hypertension clinic. Pharmacotherapy 2002; 22: 1533-40.
19. Taylor CT, Byrd DC, Krueger K. Improving primary care in rural Alabama with a pharmacy initiative. Am J Health Syst Pharm 2003; 60: 1123-9.
20. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Issues in conducting randomized controlled trials of health services research interventions in nonacademic practice settings: the case of retail pharmacies. Health Serv Res 2002; 37: 1067-77.
21. Barnett CW, Nykamp D, Ellington AM. Patient-guided counseling in the community pharmacy setting. J Am Pharm Assoc (Wash) 2000; 40: 765-72.
22. Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing 2001; 30: 205-11.
23. Jameson JP, VanNoord GR. Pharmacotherapy consultation on polypharmacy patients in ambulatory care. Ann Pharmacother 2001; 35: 835-40.
24. Simpson SH, Johnson JA, Biggs C, Biggs RS, Kuntz A, Semchuk W, et al. Study of Cardiovascular Risk Intervention by Pharmacist Investigators. Practice-based research: lessons from community pharmacist participants. Pharmacotherapy 2001; 21: 731-9.
25. McLean W, Gillis J, Waller R. The BC community pharmacy asthma study: a study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J 2003; 10: 195-202.
26. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000; 20: 1149-58.
27. Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy 2000; 20: 1508-16.
28. Nola KM, Gourley DR, Portner TS, Gourley GK, Solomon DK, Elam M, et al. Clinical and humanistic outcomes of a lipid management program in the community pharmacy setting. J Am Pharm Assoc (Wash) 2000; 40: 166-73.
29. Roberts MB, Keith MR. Implementing a performance evaluation system in a correctional managed care pharmacy. Am J Health Syst Pharm 2002; 59: 1097-104.
30. Ohno K, Miyazawa S, Hashiguchi M, Unemoto T, Itoh A, Echizen H, et al. Establishing a comprehensive questionnaire for detecting drug-induced extrapyramidal symptoms. Yakugaku Zasshi 2003; 123: 881-6.
31. Okano GJ, Malone DC, Billups SJ, Carter BL, Sintek CD, Covey D, et al. Reduced quality of life in veterans at risk for drug-related problems. Pharmacotherapy 2001; 21: 1123-9.
32. Gourley GK, Gourley DR, La Monica Rigolosi E, Reed P, Solomon DK, Washington E. Development and validation of the pharmaceutical care satisfaction questionnaire. Am J Manag Care 2001; 7: 461-6.
33. Emmerton L, Shaw J, Kheir N. Asthma management by New Zealand pharmacists: a pharmaceutical care demonstration project. J Clin Pharm Ther 2003; 28: 395-402.
34. Fischer LR, Defor TA, Cooper S, Scott LM, Boonstra DM, Eelkema MA, et al. Pharmaceutical care and health care utilization in an HMO. Eff Clin Pract 2002; 5: 49-57.
35. Fischer LR, Scott LM, Boonstra DM, DeFor TA, Cooper S, Elkema MA, et al. Pharmaceutical care for patients with chronic conditions. J Am Pharm Assoc (Wash) 2000; 40: 174-80.
36. Schulz M, Verheyen F, Muhlig S, Muller JM, Muhlbauer K, Knop-Schneickert E, et al. Pharmaceutical care services for asthma patients: a controlled intervention study. J Clin Pharmacol 2001; 41: 668-76.
37. Cranor CW, Christensen DB. The asheville project: factors associated with outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003; 43: 160-72.
38. Cranor CW, Bunting BA, Christensen DB. The asheville project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc (Wash) 2003; 43: 173-84.
39. Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 2001; 35: 1004-9.
40. Bjorkman IK, Fastbom J, Schmidt IK, Bernsten CB. Pharmaceutical Care of the Elderly in Europe Research (PEER) Group. Drug-drug interactions in the elderly. Ann Pharmacother 2002; 36: 1675-81.
41. Herborg H, Soendergaard B, Froekjaer B, Fonnesbaek L, Jorgensen T. Improving drug therapy for patients with asthma-part 1: patient outcomes. J Am Pharm Assoc (Wash) 2001; 41: 539-50.
42. Chabot I, Moisan J, Gregoire JP, Milot A. Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003; 37: 1186-93.
43. Buurma H, de Smet PA, van den Hoff OP, Sysling H, Storimans M, Egberts AC. Frequency, nature and determinants of pharmacy compounded medicines in dutch community pharmacies. Pharm World Sci 2003; 25: 280-7.
44. Bieszk N, Patel R, Heaberlin A, Wlasuk K, Zarowitz B. Detection of medication nonadhrence through review of pharmacy claims data. Am J Health Syst Pharm 2003; 60: 360-6.
45. Carter BL, Malone DC, Valuck RJ, Bamette DJ, Sintek CD, Billups SJ. The IMPROVE study: background and study design. Impact of managed pharmaceutical care on resource utilization and outcomes in veterans affairs medical centers. Am J Health Syst Pharm 1998; 55: 62-7.
46. Hanlon JT, Weinberger M, Samsa G, Schmader KE, Uttech KM, Lewis IK, et al. A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. The American Journal of Medicine 1996; 100: 428-37.
47. Knobel H, Alonso J, Casado JL, Collazos J, Gonzalez J, Ruiz I, et al. On behalf of the GEEMA Study Group. Validation of a simplified medication adherente questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. AIDS 2002; 16: 605-13.
48. Anonymous. Pharmaceutical care in long-term treatment. European society of clinical pharmacy. Pharm World Sci 1993; 15: J1-11.
49. Schroeder K, Fahey T, Ebrahim S. Interventions for improving adherence to treatment in patients with high blood pressure in ambulatory setting. Cochrane Database of Systematic Reviews 2004: 3.
50. Renders CM, Valk GD, Griffin S, Wagner E, Eijk J van, Assendelft W. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. Cochrane Database of Systematic Reviews 2004; 3.
51. Beney J, Bero LA, Bond C. Cochrane effective practice and organisation of care group. Expanding the roles of outpatient pharmacists. Cochrane Database of Systematic Reviews 2004; 3.
52. García Marco D. Seguimiento clínico de pacientes con nutricion parenteral [tesis doctoral]. Madrid: Universidad Complutense, 1995.
53. Ortiz Vergara M. Alimentación del lactante en la provincia de granada: intervención del pediatra y del farmacéutico [tesis doctoral]. Granada: Universidad de Granada, 1998.
54. Larrubia Cara M. Evaluación del estado nutricional de enfermes con insuficiencia renal crónica ante una intervention dietética con dieta hipoproteica [tesis doctoral]. Granada: Universidad de Granada, 2002.
55. Pérez Montero MP. Impacto de un protocolo sobre estreñimiento en la utilización de laxantes, en la Comunidad Foral de Navarra [tesis doctoral]. Pamplona: Universidad de Navarra, 2000.
56. Machuca González M. Influencia de la intervencion farmacé́utica en el cumplimiento de los tratamientos con antibioticos [tesis doctoral]. Seville: Universidad Hispalense, 1999.
57. Martínez Vázquez MJ. Impacto clínico y económico de una intervencion farmacéutica para promover el uso de la terapia secuencial con cuatro antibióticos [tesis doctoral]. Santiago de Compostela: Universidad de Santiago de Compostela, 2000.
58. González Vitaller R. Participatión del farmacéutico clínico en la elaboratión, interventión y valoración de los resultados de la aplicación de un protocolo multidisciplinario de analgésicos [tesis doctoral]. Barcelona: Universidad de Barcelona, 1995.
59. Díaz Baguena M. Utilización hospitalaria de fármacos cerebroactivos en pacientes geriátricos. Análisis de la medicatión general asociada [tesis doctoral]. Sevilla: Universidad Hispalense, 1991.
60. Rangel Mayoral JF. Seguimiento farmacoterapéutico y evaluatión económica de pacientes VIH+ [tesis doctoral]. Sevilla: Universidad Hispalense, 2001.
61. Estepa Alonso MJ. Seguimiento clínico y evaluatión económica de los tratamientos en pacientes con cáncer de pulmón no microcítico estado avanzado [tesis doctoral]. Sevilla: Universidad Hispalense, 2001.
62. Pérez Alberni A. Atención farmacéutica en la hipertensión arterial [tesis doctoral]. Granada: Universidad de Granada, 1998.
63. Andrès Jàcome J. Impacto de un programa de atención farmacéutica comunitaria en pacientes con asma bronquial [tesis doctoral]. Madrid: Universidad Complutense, 2001.
64. Delgado Silveira E. Informatión de medicamentos al paciente anciano. Facultad de Farmacia [tesis doctoral]. Madrid: Universidad Complutense, 1999.
65. Barbero González JA. Consulta farmacéutica en farmacia comunitaria. Facultad de Farmacia [tesis doctoral]. Madrid: Universidad de Alcalá de Henares, 2000.
66. Planells Herrero CD. Contributión al estudio de las reacciones adversas a medicamentos que motivan el ingreso hospitalario [tesis doctoral]. Universidad de Valencia, 1990.
67. Arana Osinaga A. Valoración de la importancia clínica de las potenciales interacciones de fármacos que se detectan en el medio hospitalario [tesis doctoral]. Bilbao: Universidad del País Vasco, 1996.
68. Plaza Guerrero L. El nuevo reto de la atención farmacéutica: la búsqueda del acuerdo entre profesionales [tesis doctoral]. Sevilla: Universidad Hispalense, 2000.
69. Paradela Carreiro A. Individualización de la farmacoterapia en un hospital desde el punto de vista de la eficiencia [tesis doctoral]. Santiago de Compostela: Universidad de Santiago de Compostela, 1999.
70. Gaudet W. Pharmaceutical care in a community-based setting: a pilot study of the economic, clinical and health-related quality of life outcomes [tesis doctoral]. Otawa: Canada University, 1999. Available at: http://www.nlc bnc.ca/obj/s4/f2/dsk2/tape17/PQDD_0004/MQ28937.pdf
71. Lai C. Situational adjustment in community pharmacy [tesis doctoral]. Otawa: Canada University, 1996.
72. Ponting, A. Assessment of learning achievement and practice outcomes: impact of a problem-based learning course in continuing pharmacy education [tesis doctoral]. Otawa: Canada University, 1995.
73. Ware JE, Sherboume CD. The MOS 36-item short form health survey (SF-36), I: conceptual framework and item selection. Med Care 1992; 30: 473-83.
74. McHorney CA, Ware JE, Raczek AE. The MOS 36-item short form health survey (SF-36), II: psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-63.
75. Stewart AL, Hays RD, Ware JE. The MOS short form general health survey: reliability and validity in a patient population. Med Care 1988; 26: 724-35.